# MiNK Therapeutics, Inc.: filings

INKT · Nasdaq · CIK 1840229 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inkt.md) · [Financials](/companies/inkt/financials.md) · [Filings](/companies/inkt/filings.md) · [Insiders](/companies/inkt/insiders.md)

## Reports and events: 71 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 117, 8-K 42, 10-Q 15, 3 13, CORRESP 7, DEF 14A 6, 10-K 5, S-8 5, UPLOAD 5, EFFECT 4, 4/A 3, ARS 3, S-3 3, 424B5 2, DRS/A 2, DRSLTR 2, PRE 14A 2, SC 13G 2, 144 1, 424B3 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, DRS 1, FWP 1, S-1 1, S-1/A 1, S-3/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 20:30 ET | [10-Q](/filings/0001193125-26-349309.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349309 |
| 2026-08-13 | 11:40 ET | [8-K](/filings/0001193125-26-347907.md) | 2.02 Results of operations | 0001193125-26-347907 |
| 2026-06-23 | 14:09 ET | [8-K](/filings/0001193125-26-278642.md) | 5.07 Shareholder vote results | 0001193125-26-278642 |
| 2026-05-15 | 20:16 ET | [10-Q](/filings/0001193125-26-226804.md) | Quarterly report, period 2026-03-31 | 0001193125-26-226804 |
| 2026-05-15 | 12:03 ET | [8-K](/filings/0001193125-26-225369.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-225369 |
| 2026-04-30 | 20:38 ET | [DEF 14A](/filings/0001193125-26-197577.md) | Proxy statement, period 2026-06-17 | 0001193125-26-197577 |
| 2026-03-31 | 20:49 ET | [10-K](/filings/0001193125-26-134813.md) | Annual report, period 2025-12-31 | 0001193125-26-134813 |
| 2026-03-31 | 12:07 ET | [8-K](/filings/0001193125-26-133346.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-133346 |
| 2026-03-27 | 14:40 ET | [8-K](/filings/0001193125-26-127931.md) | 8.01 Other events | 0001193125-26-127931 |
| 2026-03-19 | 21:21 ET | [8-K](/filings/0001193125-26-116219.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-116219 |
| 2026-01-02 | 21:05 ET | [8-K](/filings/0001193125-26-000916.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-000916 |
| 2025-12-08 | 21:10 ET | [8-K](/filings/0001193125-25-311229.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-311229 |
| 2025-11-14 | 21:05 ET | [10-Q](/filings/0001193125-25-282905.md) | Quarterly report, period 2025-09-30 | 0001193125-25-282905 |
| 2025-09-29 | 13:14 ET | [8-K](/filings/0001193125-25-221863.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-221863 |
| 2025-08-14 | 20:17 ET | [10-Q](/filings/0000950170-25-108894.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108894 |
| 2025-08-14 | 11:35 ET | [8-K](/filings/0001171843-25-005405.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005405 |
| 2025-07-15 | 11:05 ET | [8-K](/filings/0001193125-25-159017.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-159017 |
| 2025-07-14 | 11:45 ET | [8-K](/filings/0000950170-25-095460.md) | 8.01 Other events | 0000950170-25-095460 |
| 2025-06-18 | 20:10 ET | [8-K](/filings/0000950170-25-087888.md) | 5.07 Shareholder vote results | 0000950170-25-087888 |
| 2025-05-15 | 20:45 ET | [10-Q](/filings/0000950170-25-072789.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072789 |
| 2025-05-15 | 11:30 ET | [8-K](/filings/0001171843-25-003207.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-003207 |
| 2025-04-30 | 20:08 ET | [DEF 14A](/filings/0000950170-25-061041.md) | Proxy statement, period 2024-12-31 | 0000950170-25-061041 |
| 2025-03-18 | 21:03 ET | [10-K](/filings/0000950170-25-041379.md) | Annual report, period 2024-12-31 | 0000950170-25-041379 |
| 2025-03-18 | 11:30 ET | [8-K](/filings/0001171843-25-001513.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001513 |
| 2025-01-21 | 21:52 ET | [8-K](/filings/0001193125-25-009595.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-009595 |
| 2024-12-20 | 21:17 ET | [DEF 14A](/filings/0001140361-24-050096.md) | Proxy statement, period 2025-01-17 | 0001140361-24-050096 |
| 2024-11-14 | 21:05 ET | [10-Q](/filings/0000950170-24-127033.md) | Quarterly report, period 2024-09-30 | 0000950170-24-127033 |
| 2024-11-14 | 12:00 ET | [8-K](/filings/0001171843-24-006360.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006360 |
| 2024-10-31 | 13:15 ET | [8-K](/filings/0000950170-24-119270.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-119270 |
| 2024-10-18 | 20:05 ET | [8-K](/filings/0000950170-24-115596.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-115596 |
| 2024-09-13 | 20:05 ET | [8-K](/filings/0000950170-24-106345.md) | 3.01 Delisting notice | 0000950170-24-106345 |
| 2024-08-30 | 20:05 ET | [8-K](/filings/0000950170-24-102321.md) | 3.01 Delisting notice | 0000950170-24-102321 |
| 2024-08-13 | 20:03 ET | [10-Q](/filings/0000950170-24-096142.md) | Quarterly report, period 2024-06-30 | 0000950170-24-096142 |
| 2024-08-13 | 11:00 ET | [8-K](/filings/0001171843-24-004721.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004721 |
| 2024-06-17 | 20:05 ET | [8-K](/filings/0000950170-24-074233.md) | 5.07 Shareholder vote results | 0000950170-24-074233 |
| 2024-05-16 | 12:02 ET | [8-K](/filings/0000950170-24-060805.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0000950170-24-060805 |
| 2024-05-14 | 11:30 ET | [8-K](/filings/0001171843-24-002826.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002826 |
| 2024-05-14 | 11:28 ET | [10-Q](/filings/0000950170-24-059081.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059081 |
| 2024-04-29 | 21:25 ET | [DEF 14A](/filings/0000950170-24-050064.md) | Proxy statement, period 2023-12-31 | 0000950170-24-050064 |
| 2024-03-21 | 20:05 ET | [10-K](/filings/0000950170-24-034672.md) | Annual report, period 2023-12-31 | 0000950170-24-034672 |
| 2024-03-21 | 11:00 ET | [8-K](/filings/0001171843-24-001514.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001514 |
| 2024-02-29 | 21:05 ET | [8-K](/filings/0000950170-24-023061.md) | 3.01 Delisting notice | 0000950170-24-023061 |
| 2024-02-14 | 23:05 ET | [SC 13D](/filings/0001193125-24-036660.md) | Ownership report, active investor | 0001193125-24-036660 |
| 2024-02-14 | 13:00 ET | [8-K](/filings/0000950170-24-014944.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950170-24-014944 |
| 2023-11-14 | 22:17 ET | [10-Q](/filings/0000950170-23-063851.md) | Quarterly report, period 2023-09-30 | 0000950170-23-063851 |
| 2023-11-09 | 12:00 ET | [8-K](/filings/0001171843-23-006910.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006910 |
| 2023-10-17 | 20:15 ET | [8-K](/filings/0000950170-23-053752.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-053752 |
| 2023-08-10 | 11:30 ET | [8-K](/filings/0001171843-23-005189.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-005189 |
| 2023-08-10 | 11:26 ET | [10-Q](/filings/0000950170-23-040958.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040958 |
| 2023-06-20 | 19:45 ET | [8-K](/filings/0000950170-23-028900.md) | 5.07 Shareholder vote results | 0000950170-23-028900 |

Page 1 of 2. [Older](/companies/inkt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.